Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma (Q33241639)

24 July 2017

title

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma (English)

1 reference

24 July 2017

main subject

hepatocellular carcinoma

1 reference

Lian-yue Yang

1

1 reference

24 July 2017

Wei-qun Lu

series ordinal

2

1 reference

24 July 2017

Geng-wen Huang

series ordinal

3

1 reference

24 July 2017

Wei Wang

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

2 May 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

6

1 reference

24 July 2017

page(s)

110

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-6-110

24 July 2017

exact match

0 references

cites work

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

CD105 is important for angiogenesis: evidence and potential applications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

The prognostic significance of clinical and pathological features in hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Active drug targeting with immunoconjugates to choroidal neovascularization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Vascular-specific growth factors and blood vessel formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Defective angiogenesis in mice lacking endoglin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Examining the technique of angiogenesis assessment in invasive breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Antibody-directed targeting of the vasculature of solid tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Clinical research advances in primary liver cancer

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Immunodetection and characterisation of soluble CD105-TGFbeta complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475877

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Expression of endoglin (CD105) in tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Histopathological analysis of angiogenic factors in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Recurrence of hepatocellular carcinoma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-110

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody

21 January 2018

1 reference

12 December 2020

Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance

1 reference

12 December 2020

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies

1 reference

12 December 2020

Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-6-110

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference